Ayo Ebunolorun Ibukunoluwa

Experience & Activities

Ayo Ebunolorun Ibukunoluwa is a distinguished scientist at the forefront of Translational Oncology and Biomarker Discovery, addressing one of the world’s most pressing health challenges, cancer. As a passionate contributor to translational cancer research, her expertise spans a wide range of advanced laboratory and molecular techniques, including cell culture, genotyping, High-Performance Liquid Chromatography (HPLC), and in silico drug discovery studies. Her research carries profound global significance, focusing on novel strategies for early detection, prevention, and effective treatment. This commitment is demonstrated by numerous publications and a patent for an innovative method of targeting HER2-positive breast cancer, providing tangible solutions to complex health challenges.

Her work is characterized by its direct translational impact, bridging the gap between laboratory discoveries and clinical applications to improve patient outcomes. Beyond the laboratory, Ayo is a proven leader and mentor, with a track record of guiding and inspiring fellow researchers. As a Fellow of the Institute of STEM Innovation and Excellence (ISIE), she leverages her multidisciplinary background to contribute to a community of innovators and further her impact on STEM research. Aspiring to lead a world-class research program, Ayo is dedicated to a career of pioneering breakthroughs in cancer therapeutics and diagnostics, ultimately striving to reduce the global burden of cancer and transform the future of patient care.